(2E,4E,6Z,8E)-8-(3,4-Dihydronaphthalen-1(2H)-ylidene)-3,7-dimethylocta-2,4,6-trienoic acid

Catalog No. :
ACRTBR218
CAS No. :
205252-57-9
Molecular Formula :
C20H22O2
Molecular Weight :
294.39

IUPAC Name:(2E,4E,6Z)-8-((E)-3,4-dihydronaphthalen-1(2H)-ylidene)-3,7-dimethylocta-2,4,6-trienoic acid

(2E,4E,6Z,8E)-8-(3,4-Dihydronaphthalen-1(2H)-ylidene)-3,7-dimethylocta-2,4,6-trienoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2E,4E,6Z,8E)-8-(3,4-Dihydronaphthalen-1(2H)-ylidene)-3,7-dimethylocta-2,4,6-trienoic acid
IUPAC Name(2E,4E,6Z)-8-((E)-3,4-dihydronaphthalen-1(2H)-ylidene)-3,7-dimethylocta-2,4,6-trienoic acid
MDL No.MFCD15832932
Molecular FormulaC20H22O2
Molecular Weight294.39
SMILESO=C(O)/C=C(C)/C=C/C=C(C)\C=C1CCCC2=C/1C=CC=C2
InChI KeyPPGNMFUMZSAZCW-VOYUZAMQSA-N
Synonym2,4,6-Octatrienoic acid, 8-(3,4-dihydro-1(2H)-naphthalenylidene)-3,7-dimethyl-, (2E,4E,6Z,8E)-;(2E,4E,6Z,8E)-8-(3,4-Dihydro-1(2H)-naphthalenylidene)-3,7-dimethyl-2,4,6-Octatrienoicacid;(9Z)-UAB30;9-cis-UAB30;9cUAB30;(2E,4E,6Z,8E)-8-(3,4-Dihydro-2H-naphthalen-1-ylidene)-3,7-dimethylocta-2,4,6-trienoic acid
CAS No.205252-57-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACRTBR218 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRTBR218 route product structure diagram
    ACRTBR218205252-57-9
Inquiry

2. ACRTBR218 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRTBR218 route product structure diagram
    ACRTBR218205252-57-9
Inquiry

Comments (0)